Method of reducing or avoiding the mutagenic activity of drugs

Details Method of reducing or avoiding the mutagenic activity of drugs Method of reducing or avoiding the mutagenic activity of drugs

1977-05-09

1982-05-04

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

424177, 424180, 424229, 424258, 424243N, 424302, A61K 3171, A61K 3700, A61K 31625, A61K 3147, A61K 31415

Patent

active

043282156

ABSTRACT:
A method for reducing or avoiding the transformation of a drug into a mutagenic metabolite in a host to whom the drug is administered, the method comprising administering an antibacterial agent to the host in conjunction with the administration of the drug.

REFERENCES:
patent: 3755406 (1973-08-01), Brenneisen et al.
Bueding et al., Experientia 32, pp. 604-605, 5-15-76.
The Merck Index, 8 Ed., 1968, Merck & Co., Inc., Rahway, N.J., p. 419.

Affiliated with

Also associated with

Rating

Method of reducing or avoiding the mutagenic activity of drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of reducing or avoiding the mutagenic activity of drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing or avoiding the mutagenic activity of drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-881529